Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
University of Chicago Cancer Research Center Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified healthcare advice, calls or treatment using a genuine physician. We are not mDs. Always confer with your dr. on University of Chicago Cancer Research Center clinical studies. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. University of Chicago Cancer Research Center Clinical research trials and University of Chicago Cancer Research Center health trials take place in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations like University of Chicago Cancer Research Center to discover treatments for all forms of conditions. University of Chicago Cancer Research Center Clinical Trials and other clinical trials allow volunteers to undergo medical treatment alternatives before they are available to the masses. Most times the test subjects undergo professional assistance for free, and every now and again they are paid for their time. Sometimes there is a cost for a University of Chicago Cancer Research Center clinical trial. Subjects typically get the best healthcare possible for their condition. Risks are a reality, nonetheless, and may include additional or frequent physician trips, medical hazards (perhaps life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with rigorous guidelines to protect clinical trials subjects.

Home > "U" Clinical Trials Sponsors > University of Chicago Cancer Research Center Clinical Trials

University of Chicago Cancer Research Center Clinical Trials



3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

BMS-247550 in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Combination Chemotherapy Plus Augmerosen in Treating Patients With Untreated Extensive-Stage Small Cell Lung Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Head and Neck Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

FR901228 in Treating Patients With Advanced Colorectal Cancer That Has Progressed After a Previous Fluorouracil-Containing Regimen
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

FR901228 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Imatinib Mesylate in Treating Patients With Myelofibrosis
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

O6-benzylguanine and Carmustine in Treating Patients with Unresectable Locally Recurrent or Metastatic Melanoma
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Tipifarnib in Treating Patients With Advanced Hematologic Cancer
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Vaccine Therapy and Interleukin-12 With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

XK469 in Treating Patients With Advanced Solid Tumors or Lymphoma
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center



University of Chicago Cancer Research Center Clinical Trials

Modify your Search

Other "U" Clinical Trials Sponsors:

U.s. Bioscience
Uab Comprehensive Cancer Center
Ucsd Cancer Center
Unc Lineberger Comprehensive Cancer Center
Unimed Pharmaceuticals
United Biomedical
United Kingdom Children's Cancer Study Group
United Kingdom Coordinating Committee On Cancer Research
United Therapeutics
Unither Pharmaceuticals
Univax Biologics Inc
University College London
University Hospitals Of Leicester
University Of Alabama
University Of Arkansas
University Of California Davis Cancer Center
University Of California, San Diego
University Of California, San Francisco
University Of Chicago Cancer Research Center
University Of Cologne
University Of Colorado Cancer Center
University Of Connecticut
University Of Edinburg
University Of Florida
University Of Freiburg
University Of Illinois
University Of Kansas
University Of Kentucky
University Of Maryland Greenebaum Cancer Center
University Of Massachusetts Medical Center
University Of Miami
University Of Michigan Comprehensive Cancer Center
University Of Minnesota Cancer Center
University Of Nebraska
University Of New Mexico
University Of Newcastle Upon-Tyne
University Of Oxford
University Of Pennsylvania Cancer Center
University Of Pittsburgh
University Of Pittsburgh Cancer Institute
University Of Rochester
University Of South Florida
University Of Southern California
University Of Tennessee
University Of Texas
University Of Utah
University Of Washington
University Of Wisconsin
University Of Wisconsin Comprehensive Cancer Center
Upjohn


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103